ATORKEM

This brand name is authorized in Nigeria.

Active ingredients

The drug ATORKEM contains one active pharmaceutical ingredient (API):

1	Atorvastatin UNII 48A5M73Z4Q - ATORVASTATIN CALCIUM TRIHYDRATE
	Atorvastatin is a selective, competitive inhibitor of HMG-CoA reductase. Atorvastatin lowers plasma cholesterol and lipoprotein serum concentrations by inhibiting HMG-CoA reductase and subsequently cholesterol biosynthesis in the liver and increases the number of hepatic LDL receptors on the cell surface for enhanced uptake and catabolism of LDL.
	Read more about Atorvastatin

Packages

This drug has been approved in Nigeria as follows:

Identifier	Form	Presentation	Description	Approval
B4-9299	Tablet	Atorkem-20 Tablet TAB 20 mg 3x10	170 RNW-PP-331702 Atorkem-20 Tablet ATORVASTATIN 20MG Atorvastatin 20mg B4-9299 Drugs Imported Products 310 Prescription Only Medicine (POM) 5/26/2023 AQUATIX PHARMACEUTICALS LIMITED, 7, Sapara Williams Street, Industrial Estate, Ikeja. Lagos. Nigeria. 7064946450 aquatixnigeria@gmail.com Synokem Pharmaceuticals Ltd, Plot No. 35-36, Sector 6-A Integrated Industrial Estate (Sidcul) Ranipur (BHEL) Haridwar-249 403 UUTT Arkhand India, India	21/12/2023

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
C10AA05	Atorvastatin	C Cardiovascular system → C10 Lipid modifying agents → C10A Lipid modifying agents, plain → C10AA HMG CoA reductase inhibitors
Discover more medicines within C10AA05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
NG	Registered Drug Product Database	B4-9299